Descrizione del progetto
Applicare le soluzioni per la salute digitale
Sulla scia di un progetto Orizzonte 2020 già premiato in passato, questo progetto SEURO, finanziato dall’UE, si propone di far progredire la ricerca sull’uso di tecnologie sanitarie digitali per l’auto-gestione delle malattie croniche per i pazienti più anziani. Nello specifico, si baserà sulla piattaforma ProACT, che è stata sviluppata per consentire agli individui over 65 che vivono in casa affetti da malattie croniche/multimorbilità di comprendere meglio e gestire in modo indipendente la propria salute e il proprio benessere. In questo contesto, SEURO coinvolge un consorzio multidisciplinare dell’UE di organizzazioni pubbliche e private per consolidare le risorse di ricerca dell’UE in un nuovo approccio globale per l’ampliamento e il trasferimento di soluzioni di assistenza digitale integrate. L’obiettivo è sviluppare tre nuovi strumenti di supporto all’implementazione per contribuire a implementare e valutare soluzioni alle esigenze dei pazienti.
Obiettivo
SEURO targets Europe’s 50 million multimorbid patients to proactively self-manage and offset the EU’s annual €700 billion cost of chronic disease management. SEURO aims to evaluate key factors to prepare organisations, localities and regions across the EU to scale, sustain and transfer the people-centred, digital integrated care platform ProACT (developed and successfully tested at proof of concept level under Horizon 2020, PHC-25-2015, Grant No. 689996). Research will aim to advance 3 novel implementation support tools. These consist of a transferability self-assessment tool (ProTransfer) to assess preparedness for solution transfer; a behavioural change framework (ProBCF) to optimise a solution to people’s needs; and an artificial intelligence (AI) prediction model (ProInsight) to assess the impact of a solution on health system performance. Effective Implementation Hybrid Trials (720 older adults in total, with associated care/support actors) will be carried out with ProACT within health services (Ireland, Belgium Sweden to measure platform effectiveness), with embedded process evaluations to understand the process for successful ‘real world’ implementation. Participants will have at least two of the following: cardiovascular disease (excluding Stroke), a respiratory condition and diabetes. Commercial potential will be validated during the project supported by an exploratory trial (Italy) to evaluate the impact of SEURO in facilitating a procurement process for healthcare service providers aiming to implement ProACT. SEURO engages a multidisciplinary EU consortium of 4 public and 8 private organisations (including one of the world's leading ICT companies, the largest home care provider and 2 EU service provider and technology networks). Partners have a successful collaborative track record. Together we are in a strong position to consolidate EU research assets into a new comprehensive approach for the scale-up and transfer of digital integrated care solutions.
Campo scientifico
- natural sciencescomputer and information sciencesartificial intelligence
- medical and health sciencesclinical medicineendocrinologydiabetes
- medical and health sciencesclinical medicinecardiologycardiovascular diseases
- medical and health sciencesbasic medicineneurologystroke
- medical and health scienceshealth scienceshealth care services
Parole chiave
Programma(i)
Invito a presentare proposte
Vedi altri progetti per questo bandoBando secondario
H2020-SC1-2020-Two-Stage-RTD
Meccanismo di finanziamento
RIA - Research and Innovation actionCoordinatore
D02 CX56 DUBLIN 2
Irlanda